Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shimizu Chemical is a Japanese life sciences company specializing in the research, development, and manufacture of konjac glucomannan-based products. The company is globally recognized for its proprietary Propol brand, a highly purified glucomannan used as a functional food ingredient, dietary fiber, and pharmaceutical excipient. Their expertise lies in the extraction and purification of polysaccharides to support metabolic health, weight management, and digestive wellness. Beyond nutraceuticals, Shimizu Chemical provides thickening and gelling agents for the cosmetics and food industries. The company maintains rigorous quality standards, including GMP and ISO certifications, to serve international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shimizu Chemical.